AML1 amplification in a case of childhood acute lymphoblastic leukemia

Cancer Genetics and Cytogenetics

Volumn 137, Issue 2, 2002, Pages 142-145

  Morel, Frédéric ^a,b   Herry, Angèle ^a,b   Le Bris, Marie Josée ^b   Douet Guilbert, Nathalie ^b,c   Le Calvez, Geneviève ^d   Marion, Véronique ^d   Berthou, Christian ^a,c   De Braekeeler, Marc ^a,e  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^b Service De Cytogénétique   (France)

^c Institut d'Hématologie Et De Carcérologie   (France)

^d CHU MORVAN   (France)

^e UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; AML1 GENE; ARTICLE; B LYMPHOCYTE; BLAST CELL; CASE REPORT; CHROMOSOME; CHROMOSOME 21; CHROMOSOME MARKER; CONTROLLED STUDY; FEMALE; FLUORESCENCE; FUSION GENE; GENE AMPLIFICATION; GENE IDENTIFICATION; HUMAN; IN SITU HYBRIDIZATION; KARYOTYPE; MEDICAL RESEARCH; PRIORITY JOURNAL; SCHOOL CHILD;

CHILD; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 21; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; FEMALE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, LYMPHOCYTIC, ACUTE; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS;

EID: 0036752643     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00566-6     Document Type: Article

References (11)

1. Watson M.S., Carroll A.J., Shuster J.J., Steuber C.P., Borowitz M.J., Behm F.G., Pullen D.J., Land V.J. Trisomy 21 in childhood acute lymphoblastic leukemia. a pediatric oncology group study (8602) Blood. 82:1993;3098-3102.
2. Romana S.P., Poirel H., Le Coniat M., Flexor M.A., Mauchauffé M., Jonveaux P., Macintyre E.A., Berger R., Bernard O.A. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood. 86:1995;4263-4269.
3. Shurtleff S.A., Buijs A., Behm F.G., Rubnitz J.E., Raimondi S.C., Hancock M.L., Chan G.C., Pui C.H., Grosveld G., Downing J.R. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia. 9:1995;1985-1989.
4. Romana S.P., Mauchauffé M., Le Coniat M., Chumakov I., Le Paslier D., Berger R., Bernard O.A. The t(12;21) of acute lymphoblastic leukemia results in a tel-aml1 gene fusion. Blood. 85:1995;3662-3670.
5. Niini T., Kanerva J., Vettenranta K., Saarinen-Pihkala U.M., Knuutila S. AML1 gene amplification. a novel finding in childhood acute lymphoblastic leukemia Haematologica. 85:2000;362-366.
6. Dal Cin P., Atkins L., Ford C., Ariyanayagam S., Armstrong S.A., George R., Cleary A., Morton C.C. Amplification of AML1 in childhood acute lymphoblastic leukemias. Genes Chromosomes Cancer. 30:2001;407-409.
7. Busson-Le Coniat M., Nguyen Khac F., Daniel M.T., Bernard O.A., Berger R. Chromosome 21 abnormalities with AML1 amplification in acute lymphoblastic leukemia. Genes Chromosomes Cancer. 32:2001;244-249.
8. Berger R. Acute lymphoblastic leukemia and chromosome 21. Cancer Genet Cytogenet. 94:1997;8-12.
9. Osato M., Asou N., Abdalla E., Hoshino K., Yamasaki H., Okubo T., Suzushima H., Takatsuki K., Kanno T., Shigesada K., Ito Y. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2aB gene associated with myeloblastic leukemias. Blood. 93:1999;1817-1824.
10. Preudhomme C., Warot-Loze D., Roumier C., Gradel-Duflos N., Garand R., Kai J.L., Dastugue N., MacIntyre E., Denis C., Bauters F., Kerckaert J.P., Cosson A., Fenaux P. High incidence of biallelic point mutations in the Runt domain of AML1/PEBP2aB gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21. Blood. 96:2000;2862-2869.
11. Lo Coco F., Pisegna S., Diverio D. The AML1 gene. a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias Haematologica. 82:1997;364-370.